
Pharming Group N.V.
Pharming Group N.V. (PHAR)
WebsitePrice
Market cap
Next catalystNov 2026Joenja® (leniolisib) — CVID Phase 2 · Phase 2 dataCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Partner / License out
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
History / paused
Financial position
Company funding outlook
Upcoming milestones
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|